Oncology Analytics
Plantation, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into Oncology Analytics
Sign up to see every warm intro you have to Oncology Analytics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncology Analytics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RW
Robert WaltonExecutive
BV
Balbino VazquezExecutive
DF
Danielle FishmanExecutive
MF
Marc FishmanNamed on SEC filing
Board
NR

TH
Thomas HawesBoard director
ML
Marc LippmanBoard director
MM
Michael MontijoBoard director
JB
John BradburnBoard director
Investors · 5
Baird CapitalreportedChicago
How we know: funding news · prnewswire.com · Not right? Tell us
McKesson VenturesreportedSan Francisco
How we know: funding news · ventures.mckesson.com · Not right? Tell us
Oak HC/FTreportedStamford
How we know: funding news · prnewswire.com · Not right? Tell us
Sandbox AdvantagereportedChicago
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
The Blue Venture Fund
Reported raises · per SEC filings
Form D private placements$53.5M disclosed across 3 rounds · 2016–2020
▶$25MraisedMay 2020 · 7 investors · Other TechnologyRule 506(b)
▶$25MraisedMay 2020 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Zeke EmanuelDirector
- Marc FishmanExecutive Officer, Director
- Peter BachDirector
- Ann LamontDirector
- Thomas HawesDirector
- Michael LiangDirector
- Michael WeintraubDirector
- Rick J. DeanExecutive Officer, Director
- Offering amount
- $28M
- Amount sold
- $25M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$21MraisedNov 2018 · 4 investors · Other TechnologyRule 506(b)
▶$21MraisedNov 2018 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nick RosaDirector
- Balbino VazquezExecutive Officer, Director
- Dipa MehtaDirector
- Marc LippmanDirector
- Zeke EmanuelDirector
- Marc FishmanExecutive Officer, Director
- Thomas HawesDirector
- Rick J. DeanExecutive Officer, Director
- Ann LamontDirector
- Offering amount
- $25M
- Amount sold
- $21M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$7.5MraisedJan 2016 · 2 investors · Other Health CareRule 506(b)
▶$7.5MraisedJan 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc FishmanExecutive Officer, Director
- Marc LippmanDirector
- Nick RosaDirector
- Michael MontijoDirector
- Robert WaltonExecutive Officer
- John BradburnDirector
- Balbino VazquezExecutive Officer, Director
- Thomas HawesDirector
- Danielle FishmanExecutive Officer
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Oncology Analytics's investors?
- Oncology Analytics's investors include Baird Capital, McKesson Ventures, Oak HC/FT, Sandbox Advantage.
- How much funding has Oncology Analytics raised?
- Oncology Analytics has disclosed $53.5M raised across 3 rounds.
- Where is Oncology Analytics headquartered?
- Oncology Analytics is headquartered in Plantation, US.


